An Integrated Genomic Analysis of Human Glioblastoma Multiforme, Science, vol.321, issue.5897, pp.1807-1812, 2008. ,
DOI : 10.1126/science.1164382
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome, New England Journal of Medicine, vol.361, issue.11, pp.1058-1066, 2009. ,
DOI : 10.1056/NEJMoa0903840
Mutations in Gliomas, New England Journal of Medicine, vol.360, issue.8, pp.765-773, 2009. ,
DOI : 10.1056/NEJMoa0808710
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, vol.50, issue.7274, pp.739-744, 2009. ,
DOI : 10.1038/nature08617
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818760
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations, The Journal of Experimental Medicine, vol.64, issue.2 ,
DOI : 10.1126/science.1170944
Leukemic IDH1 and IDH2 Mutations Result in??a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation, Cancer Cell, vol.18, issue.6, pp.553-567, 2010. ,
DOI : 10.1016/j.ccr.2010.11.015
Cancer-associated IDH mutations: biomarker and therapeutic opportunities, Oncogene, vol.324, issue.49, pp.6409-6417, 2010. ,
DOI : 10.1038/onc.2010.444
) occur frequently in high-grade gliomas but not in other solid tumors, Human Mutation, vol.279, issue.1, pp.7-11, 2009. ,
DOI : 10.1002/humu.20937
Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers, International Journal of Cancer, vol.279, issue.2, pp.353-355, 2009. ,
DOI : 10.1002/ijc.24379
Pathobiology and Molecular Profiling of Peripheral T-Cell Lymphomas, Hematology, vol.2008, issue.1, pp.272-279, 2008. ,
DOI : 10.1182/asheducation-2008.1.272
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma, Blood, vol.115, issue.5, pp.1026-1036, 2010. ,
DOI : 10.1182/blood-2009-06-227579
High-throughput oncogene mutation profiling in human cancer, Nature Genetics, vol.62, issue.3, pp.347-51, 2007. ,
DOI : 10.1093/nar/gnh069
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is??a Recurrent Event during Human Lymphomagenesis, Cancer Cell, vol.20, issue.1, pp.25-38, 2011. ,
DOI : 10.1016/j.ccr.2011.06.003
Advances in the understanding and management of angioimmunoblastic T-cell lymphoma, British Journal of Haematology, vol.9, issue.Suppl. 2, pp.673-689, 2010. ,
DOI : 10.1111/j.1365-2141.2009.08003.x
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials, Blood, vol.111, issue.9, pp.4463-4470, 2008. ,
DOI : 10.1182/blood-2007-08-105759
URL : https://hal.archives-ouvertes.fr/inserm-00282621
Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with ,
The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells, Blood, vol.109, issue.11, pp.4952-4963, 2007. ,
DOI : 10.1182/blood-2006-10-055145
The prognostic significance of IDH2 mutations in AML depends on the location of the mutation, Blood, vol.118, issue.2, pp.409-412, 2011. ,
DOI : 10.1182/blood-2010-12-322479
AITL) 0/79 15/79 1/79 UNMC patients Angioimmunoblastic T-cell lymphoma (AITL) 0, p.1022 ,